Working… Menu

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00791570
Recruitment Status : Completed
First Posted : November 14, 2008
Last Update Posted : October 16, 2012
Human Genome Center, Institute of Medical Science, University of Tokyo
Information provided by:
Osaka University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2012
Actual Study Completion Date : April 2012